Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 9/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18156095 | 0.90 | PPARA (0.41) | FFAR4PPARAFFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18156379 | 0.90 | FFAR4 (0.42) | FFAR4PPARAFFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18182279 | 0.90 | FFAR4 (0.42) | FFAR4PPARAFFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18156250 | 0.90 | ALOX15 (0.40) | FFAR4ALOX15FFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18182540 | 0.90 | SLC22A12 (0.46) | FFAR4PPARAALOX15FFAR1MRGPRX4 | |
| SCHEMBL18178476 | 0.88 | MRGPRX4 (0.47) | FFAR4FFAR1MRGPRX4ACHE | |
| SCHEMBL18156119 | 0.88 | FFAR4 (0.46) | FFAR4PPARAALOX15FFAR1MRGPRX4 | |
| SCHEMBL18183108 | 0.88 | FFAR4 (0.40) | FFAR4PPARAFFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18183017 | 0.88 | CYP1A2 (0.43) | ALOX15CD274 | |
| SCHEMBL18156407 | 0.88 | NPC1 (0.41) | ALOX15MRGPRX4CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573904-B2 | Aromatic compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3081559-A1 | AROMATIC COMPOUND AND APPLICATION FOR SAME | Sumitomo Chemical Company, Limited (JP) | 2016-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | ZCCHC8, CBR3, CBX8 | FFAR4 2485/4885PPARA 3076/4885ALOX15 3233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.